Search by keyword

Research Seminar: Do remedies hurt the performance of M&As? Evidence from M&As scrutinized by the EU competition authority.

Research Seminar: Do remedies hurt the performance of M&As? Evidence from M&As scrutinized by the EU competition authority.

Nazarbayev University Graduate School of Business invites you to the Research Seminar titled “Do remedies hurt the performance of M&As? Evidence from M&As scrutinized by the EU competition authority”, presented by Valentina Fani.

Abstract

This study examines the performance implications of remedies adopted during the investigation of Mergers & Acquisitions by the competition authority. The adoption of remedies in M&As is a prevalent phenomenon that has received little attention. Remedies can involve the loss of ownership (i.e., structural remedies) or limit the control (i.e., behavioral remedies) over some of the firm assets. We argue that the adoption of remedies risks diminishing the market power effects of M&As. Yet, the loss of control over some assets can create opportunities for reshaping the business landscape and significantly enhance acquisition performance. Analyses of data on a sample of 1714 M&As examined by the European Commission show overall a positive relationship between remedies and acquisition performance.

Time: 6 pm - 7 pm

Area: Strategy

REGISTRATION HERE


Add to your calendar

Date:

Wednesday, February 24, 2021

Time:

18:00

Location:

ZOOM

Speaker

Valentina Fani

Ph.D. candidate in the Strategy, Globalization and Society department at HEC Lausanne

Valentina Fani is a Ph.D. candidate in the Strategy, Globalization and Society department at HEC Lausanne (Switzerland). Her doctoral thesis aims to provide new insights on corporate strategy, with a particular interest in the intersection of mergers & acquisitions, competition, and competition policy.